Hypnosis for irritable bowel syndrome: The quest for the mechanism of action

International Journal of Clinical and Experimental Hypnosis

Volumn 54, Issue 1, 2006, Pages 65-84

  Simrén, Magnus ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Section of Gastroenterology and Hepatology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTIDEPRESSANT AGENT; BULKING AGENT; LOPERAMIDE; SPASMOLYTIC AGENT; TEGASEROD;

AUTONOMIC NERVOUS SYSTEM; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CONSTIPATION; DIARRHEA; GASTROINTESTINAL MOTILITY; HUMAN; HYPNOSIS; IRRITABLE COLON; PAIN; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW;

AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIALS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; HUMANS; HYPNOSIS; INTESTINES; IRRITABLE BOWEL SYNDROME; TREATMENT OUTCOME;

EID: 28844506795     PISSN: 00207144     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207140500327239     Document Type: Review

References (93)

1. Aggarwal, A., Cutts, T. F., Abell, T. L., Cardoso, S., Familoni, B., & Bremer, J. et al. (1994). Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities. Gastroenterologey, 106, 945-950.
2. Agreus, L. (1993). Socio-economic factors, health care consumption and rating of abdominal symptom severity. A report from the abdominal symptom study. Family Practice, 10, 152-163.
3. Agreus, L., Svardsudd, K., Nyren, O., & Tibblin, G. (1995). Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time. Gastroenterology, 109, 671-680.
4. Azpiroz, F., & Malagelada, J. R. (1985). Intestinal control of gastric tone. American Journal of Physiology, 249(4 Pt 1), G501-509.
5. Beaugerie, L., Burger, A. J., Cadranel, J. F., Lamy, P., Gendre, J. P., & Le Quintrec, Y. (1991). Modulation of orocaecal transit time by hypnosis. Gut, 32, 393-394.
6. Bennett, E. J., Tennant, C. C., Piesse, C., Badcock, C. A., & Kellow, J. E. (1998). Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut, 43, 256-261.
7. Björnsson, E., Sjoberg, J., Ringström, G., Norström, M., Simrén, M., & Abrahamsson, H. (2003). Effects of duodenal lipids on gastric sensitivity and relaxation in patients with ulcer-like and dysmotility-like dyspepsia. Digestion, 67, 209-217.
8. Blanchard, E. B., Greene, B., Scharff, L., & Schwarz-McMorris, S. P. (1993). Relaxation training as a treatment for irritable bowel syndrome. Biofeedback and Self-Regulation, 18, 125-132.
9. Bonaz, B., Baciu, M., Papillon, E., Bost, R., Gueddah, N., & Le Bas, J. F. et al. (2002). Central processing of rectal pain in patients with irritable bowel syndrome: An fMRI study. American Journal of Gastroenterology, 97, 654-661.
10. Bouin, M., Plourde, V., Boivin, M., Riberdy, M., Lupien, F., & Laganiere, M., et al. (2002). Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology, 122, 1771-1777.
11. Camilleri, M., Coulie, B., & Tack, J. F. (2001). Visceral hypersensitivity: Facts, speculations, and challenges. Gut, 48, 125-131.
12. Camilleri, M., Northcutt, A. R., Kong, S., Dukes, G. E., McSorley, D., & Mangel, A. W. (2000). Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial. Lancet, 355(9209), 1035-1040.
13. Camilleri, M., & Williams, D. E. (2000). Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures. Pharmacoeconomics, 17, 331-338.
14. Chey, W. Y., Jin, H. O., Lee, M. H., Sun, S. W., & Lee, K. Y. (2001). Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. American Journal of Gastroenterology, 96, 1499-1506.
15. Dancey, C. P., Taghavi, M., & Fox, R. J. (1998). The relationship between daily stress and symptoms of irritable bowel: A time-series approach. Journal of Psychosomatic Research, 44, 537-545.
16. Delvaux, M. (2002). Do we need to perform rectal distention tests to diagnose IBS in clinical practice?. Gastroenterology, 122, 2075-2078.
17. Dickhaus, B., Mayer, E. A., Firooz, N., Stains, J., Conde, F., & Olivas, T. I., et al. (2003). Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. American Journal of Gastroenterology, 98, 135-143.
18. Drossman, D. A. (1999). Review article: An integrated approach to the irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 13 (Suppl. 2), 3-14.
19. Drossman, D. A., Leserman, J., Li, Z., Keefe, F., Hu, Y. J., & Toomey, T. C. (2000). Effects of coping on health outcome among women with gastrointestinal disorders. Psychosomatic Medicine, 62, 309-317.
20. Drossman, D. A., Li, Z., Leserman, J., Toomey, T. C., & Hu, Y. J. (1996). Health status by gastrointestinal diagnosis and abuse history. Gastroenterology, 110, 999-1007.
21. Drossman, D. A., McKee, D. C., Sandler, R. S., Mitchell, C. M., Cramer, E. M., & Lowman, B. C., et al. (1988). Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology, 95, 701-708.
22. Elsenbruch, S., & Orr, W. C. (2001). Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses. American Journal of Gastroenterology, 96, 460-466.
23. Faymonville, M. E., Laureys, S., Degueldre, C., Del Fiore, G., Luxen, A., & Franck, G. et al. (2000). Neural mechanisms of antinociceptive effects of hypnosis. Anesthesiology, 92, 1257-1267.
24. Faymonville, M. E., Roediger, L., Del Fiore, G., Delgueldre, C., Phillips, C., & Lamy, M. et al. (2003). Increased cerebral functional connectivity underlying the antinociceptive effects of hypnosis. Brain Research: Cognitive Brain Research, 17, 255-262.
25. Forbes, A., MacAuley, S., & Chiotakakou-Faliakou, E. (2000). Hypnotherapy and therapeutic audiotape: Effective in previously unsuccessfully treated irritable bowel syndrome? International Journal of Colorectal Disease, 15(5-6), 328-334.
26. Ford, M. J., Miller, P. M., Eastwood, J., & Eastwood, M. A. (1987). Life events, psychiatric illness and the irritable bowel syndrome. Gut, 28, 160-165.
27. Galovski, T. E., & Blanchard, E. B. (1998). The treatment of irritable bowel syndrome with hypnotherapy. Applied Psychophysiology and Biofeedback, 23, 219-232.
28. Gonsalkorale, W. M., Houghton, L. A., & Whorwell, P. J. (2002). Hypnotherapy in irritable bowel syndrome: A large-scale audit of a clinical service with examination of factors influencing responsiveness. American Journal of Gastroenterology, 97, 954-961.
29. Gonsalkorale, W. M., Miller, V., Afzal, A., & Whorwell, P. J. (2003). Long-term benefits of hypnotherapy for irritable bowel syndrome. Gut, 52, 1623-1629.
30. Gonsalkorale, W. M., Toner, B. B., & Whorwell, P. J. (2004). Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome. Journal of Psychosomatic Research, 56, 271-278.
31. Gould, R. C., & Krynicki, V. E. (1989). Comparative effectiveness of hypnotherapy on different psychological symptoms. American Journal of Clinical Hypnosis, 32(2), 110-117.
32. Guthrie, E., Creed, F., Dawson, D., & Tomenson, B. (1991). A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology, 100, 450-457.
33. Harvey, R. F., Hinton, R. A., Gunary, R. M., & Barry, R. E. (1989). Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet, 1(8635), 424-425.
34. Heaton, K. W., O'Donnell, L. J., Braddon, F. E., Mountford, R. A., Hughes, A. O., & Cripps, P. J. (1992). Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology, 102, 1962-1967.
35. Heitkemper, M., Jarrett, M., Cain, K. C., Burr, R., Levy, R. L., & Feld, A., et al. (2001). Autonomic nervous system function in women with irritable bowel syndrome. Digestive Diseases and Sciences, 46, 1276-1284.
36. Hobson, A. R., & Aziz, Q. (2004). Brain imaging and functional gastrointestinal disorders: Has it helped our understanding? Gut, 53, 1198-1206.
37. Houghton, L. A., Calvert, E. L., Jackson, N. A., Cooper, P., & Whorwell, P. (2002). Visceral sensation and emotion: A study using hypnosis. Gut, 51, 701-704.
38. Houghton, L. A., Heyman, D. J., & Whorwell, P. J. (1996). Symptomatology, quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy. Alimentary Pharmacologyy and Therapeutics, 10, 91-95.
39. Jackson, J. L., O'Malley, P. G., Tomkins, G., Balden, E., Santoro, J., & Kroenke, K. (2000). Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis. American Journal of Medicine, 108, 65-72.
40. Jailwala, J., Imperiale, T. F., & Kroenke, K. (2000). Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials. Annals of Internal Medicine, 133, 136-147.
41. Kellow, J. E., & Phillips, S. F. (1987). Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology, 92, 1885-1893.
42. Klein, K. B. (1988). Controlled treatment trials in the irritable bowel syndrome: A critique. Gastroenterology, 95, 232-241.
43. Lea, R., Houghton, L. A., Calvert, E. L., Larder, S., Gonsalkorale, W. M., & Whelan, V., et al. (2003). Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 17, 635-642.
44. Mayer, E. A., & Gebhart, G. F. (1994). Basic and clinical aspects of visceral hyperalgesia. Gastroenterology, 107, 271-293.
45. McKee, D. P., & Quigley, E. M. (1993a). Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder? Part 1. Definition of IBS and colonic motility. Digestive Diseases and Sciences, 38, 1761-1772.
46. McKee, D. P., & Quigley, E. M. (1993b). Intestinal motility in irritable bowel syndrome: Is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall bladder. Digestive Diseases and Sciences, 38, 1773-1782.
47. Mertz, H., Morgan, V., Tanner, G., Pickens, D., Price, R., & Shyr, Y., et al. (2000). Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology, 118, 842-848.
48. Mertz, H., Naliboff, B., Munakata, J., Niazi, N., & Mayer, E. A. (1995). Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology, 109, 40-52.
49. Miller, A. R., North, C. S., Clouse, R. E., Wetzel, R. D., Spitznagel, E. L., & Alpers, D. H. (2001). The association of irritable bowel syndrome and somatization disorder. Annals of Clinical Psychiatry, 13, 25-30.
50. Muller-Lissner, S. A., Fumagalli, I., Bardhan, K. D., Pace, F., Pecher, E., & Nault, B., et al. (2001). Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Alimentary Pharmacology & Therapeutics, 15, 1655-1666.
51. Naliboff, B. D., Derbyshire, S. W., Munakata, J., Berman, S., Mandelkern, M., & Chang, L., et al. (2001). Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosomatic Medicine, 63, 365-375.
52. Naliboff, B. D., Munakata, J., Fullerton, S., Gracely, R. H., Kodner, A., & Harraf, F., et al. (1997). Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut, 41, 505-512.
53. Narducci, F., Bassotti, G., Granata, M. T., Pelli, M. A., Gaburri, M., & Palumbo, R., et al. (1986). Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Digestive Diseases and Sciences, 31, 241-246.
54. Österberg, E., Blomquist, L., Krakau, I., Weinryb, R. M., Asberg, M., & Hultcrantz, R. (2000). A population study on irritable bowel syndrome and mental health. Scandinavian Journal of Gastroenterology, 35, 264-268.
55. Palsson, O. S., Turner, M. J., Johnson, D. A., Burnelt, C. K., & Whitehead, W. E. (2002). Hypnosis treatment for severe irritable bowel syndrome: Investigation of mechanism and effects on symptoms. Digestive Diseases and Sciences, 47, 2605-2614.
56. Posserud, I., Agerforz, P., Ekman, R., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2004). Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut, 53, 1102-1108.
57. Posserud, I., Ringström, G., Agerforz, P., Björnsson, E., Abrahamsson, H., & Simrén, M. (2003). Visceral hypersensitivity and relation to symptoms in the irritable bowel syndrome (IBS). Gastroenterology, 124 (4:Suppl 1), 124.
58. Prior, A., Colgan, S. M., & Whorwell, P. J. (1990). Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut, 31, 896-898.
59. Rainville, P., Duncan, G. H., Price, D. D., Carrier, B., & Bushnell, M. C. (1997). Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science, 277(5328), 968-971.
60. Rainville, P., Hofbauer, R. K., Paus, T., Duncan, G. H., Bushnell, M. C., & Price, D. D. (1999). Cerebral mechanisms of hypnotic induction and suggestion. Journal of Cognitive Neuroscience, 11, 110-125.
61. Ritchie, J. (1973). Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut, 14, 125-132.
62. Rogers, J., Henry, M. M., & Misiewicz, J. J. (1989). Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut, 30, 634-641.
63. Saito, Y. A., Schoenfeld, P., & Locke, G. R., 3rd (2002). The epidemiology of irritable bowel syndrome in North America: A systematic review. American Journal of Gastroenterology, 97, 1910-1915.
64. Sandler, R. S., Drossman, D. A., Nathan, H. P., & McKee, D. C. (1984). Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology, 87, 314-318.
65. Silverman, D. H., Munakata, J. A., Ennes, H., Mandelkern, M. A., Hoh, C. K., & Mayer, E. A. (1997). Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology, 112, 64-72.
66. Simrén, M. (2003). Quality of life in irritable bowel syndrome: Measurement techniques and relevance of current knowledge. Expert Review of Pharmacoeconomics & Outcomes Research, 3, 75-88.
67. Simrén, M., Abrahamsson, H., & Björnsson, E. S. (2001). An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut, 48, 20-27.
68. Simrén, M., Abrahamsson, H., Svedlund, J., & Björnsson, E. S. (2001). Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: The impact of gender and predominant bowel pattern. Scandinavian Journal of Gastroenterology, 36, 545-552.
69. Simrén, M., Castedal, M., Svedlund, J., Abrahamsson, H., & Björnsson, E. (2000). Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS). Digestive Diseases and Sciences, 45, 2151-2161.
70. Simrén, M., Månsson, A., Langkilde, A. M., Svedlund, J., Abrahamsson, H., & Bengtsson, U., et al. (2001). Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion, 63, 108-115.
71. Simrén, M., Ringstrom, G., Björnsson, E. S., & Abrahamsson, H. (2004). Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosomatic Medicine, 66, 233-238.
72. 3-receptors. Alimentary Pharmacology & Therapeutics, 17, 279-287.
73. Steadman, C. J., Phillips, S. F., Camilleri, M., Haddad, A. C., & Hanson, R. B. (1991). Variation of muscle tone in the human colon. Gastroenterology, 101, 373-381.
74. Svedlund, J., Sjodin, I., Ottosson, J. O., & Dotevall, G. (1983). Controlled study of psychotherapy in irritable bowel syndrome. Lancet, 2(8350), 589-592.
75. Talley, N. J., Boyce, P. M., & Jones, M. (1997). Predictors of health care seeking for irritable bowel syndrome: A population based study. Gut, 41, 394-398.
76. Talley, N. J., Boyce, P. M., & Jones, M. (1998). Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population-based study. Gut, 42, 47-53.
77. Talley, N. J., Owen, B. K., Boyce, P., & Paterson, K. (1996). Psychological treatments for irritable bowel syndrome: A critique of controlled treatment trials. American Journal of Gastroenterology, 91, 277-283.
78. Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Muller-Lissner, S. A. (1999). Functional bowel disorders and functional abdominal pain. Gut, 45(Suppl 2), I), 143-47.
79. Toner, B. B. (1994). Cognitive-behavioral treatment of functional somatic syndromes: Integrating gender issues. Cognitive and Behavioral Practice, 1, 157-178.
80. Vassallo, M. J., Camilleri, M., Phillips, S. F., Steadman, C. J., Talley, N. J., & Hanson, R. B., et al. (1992). Colonic tone and motility in patients with irritable bowel syndrome [see comments]. Mayo Clinic Procedures, 67, 725-731.
81. Vidakovic-Vukic, M. (1999). Hypnotherapy in the treatment of irritable bowel syndrome: Methods and results in Amsterdam. Scandinavian Journal of Gastroenterology, 34(Suppl 230), 49-51.
82. Welgan, P., Meshkinpour, H., & Beeler, M. (1988). Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology, 94, 1150-1156.
83. Welgan, P., Meshkinpour, H., & Hoehler, F. (1985). The effect of stress on colon motor and electrical activity in irritable bowel syndrome. Psychosomatic Medicine, 47, 139-149.
84. Whitehead, W. E., Bosmajian, L., Zonderman, A. B., Costa, P. T., Jr., & Schuster, M. M. (1988). Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology, 95, 709-714.
85. Whitehead, W. E., Crowell, M. D., Robinson, J. C., Heller, B. R., & Schuster, M. M. (1992). Effects of stressful life events on bowel symptoms: Subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut, 33, 825-830.
86. Whitehead, W. E., & Delvaux, M. (1997). Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Digestive Diseases and Sciences, 42, 223-241.
87. Whitehead, W. E., & Palsson, O. S. (1998). Is rectal pain sensitivity a biological marker for irritable bowel syndrome: Psychological influences on pain perception. Gastroenterology, 115, 1263-1271.
88. Whorwell, P. J., Houghton, L. A., Taylor, E. E., & Maxton, D. G. (1992). Physiological effects of emotion: Assessment via hypnosis. Lancet, 340(8811), 69-72.
89. Whorwell, P. J., McCallum, M., Creed, F. H., & Roberts, C. T. (1986). Non-colonic features of irritable bowel syndrome. Gut, 27, 37-40.
90. Whorwell, P. J., Prior, A., & Colgan, S. M. (1987). Hypnotherapy in severe irritable bowel syndrome: Further experience. Gut, 28, 423-425.
91. Whorwell, P. J., Prior, A., & Faragher, E. B. (1984). Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet, 2(8414), 1232-1234.
92. Wiley, J., Tatum, D., Keinath, R., & Owyang, C. (1988). Participation of gastric mechanoreceptors and intestinal chemoreceptors in the gastrocolonic response. Gastroenterology, 94(5 Pt 1), 1144-1149.
93. Wright, S. H., Snape, W. J., Jr., Battle, W., Cohen, S., & London, R. L. (1980). Effect of dietary components on gastrocolonic response. American Journal of Physiology, 238, G228-232.